Intimation of investors meeting.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed stock exchanges that its officials will participate in a group investor meeting arranged by Goldman Sachs. The meeting is scheduled for June 17, 2025, from 2:00 PM to 3:30 PM IST in Hyderabad. It will be an in-person group meeting. The company clarified that no unpublished price sensitive information (UPSI) will be discussed during the interaction. The schedule remains subject to change due to exigencies on either side.
This is a routine investor engagement announcement with no material business impact. The fact that no UPSI will be shared signals this is a non-event for the stock, though attendance at a Goldman Sachs-arranged meeting keeps the stock on institutional investors' radar.